Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...

During sleep, norepinephrine triggers rhythmic constriction of blood vessels independent of a person's heartbeat, researchers found. This oscillation generates the pumping action that powers the ...

Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder (MDD) in adults who do not respond to ...

The standard-of-care for MDD typically involves selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine ... J says this drug delivers rapid action. MDD is a severe, chronic ...

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...

What has puzzled researchers and philosophers for many centuries is the ‘why’ of sleep, along with the ‘how’. We human ...

The question of putative mechanisms of action continues to haunt psychopharmacology ... a disease of deficit of either serotonin or norepinephrine. Lately, we have been focused on the idea ...

Research indicates that following the onset of an acquired brain injury (ABI), the brain initiates an immediate ...

Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter.